Neural Co-Culture Cellular Model Development Service

Creative Biolabs provides custom neural co-culture cellular model development for studies in which neuronal behavior depends on astrocytes, microglia, oligodendroglial cells, Schwann cells, endothelial cells, muscle, or another disease-relevant partner population. The service supports neural maturation, cell-cell signaling, neuroinflammation, neurodegeneration, myelination, axonal injury, neurotoxicity, target validation, and therapeutic efficacy questions that cannot be resolved reliably in a neuron-only culture.

Programs can connect with our custom cell culture model development service, cell culture models, and in vitro neuroscience services.

Study Strategy

A co-culture adds value only when the partner cell changes the biological decision. For some programs, the goal is to accelerate or stabilize neuronal maturation. For others, the key variable is a paracrine inflammatory signal, phagocytic clearance, myelin support, barrier communication, axonal contact, or treatment response that emerges only when two or more cell populations interact. We therefore define which interaction must be preserved before selecting cells, geometry, medium, and readouts.

The initial design resolves questions such as:

• Causal compartment: Which cell initiates the phenotype, which cell receives the signal, and does the study need physical contact, soluble signaling, extracellular vesicles, matrix interaction, or electrical activity?
• Research decision: Is the output intended for model qualification, mechanism confirmation, target validation, compound ranking, dose selection, safety review, biomarker discovery, or a transition to a 3D or in vivo model?
• Cell provenance: Must the system use primary human or rodent cells, matched iPSC-derived cells, disease and control donors, isogenic edits, or a practical screening line?
• Temporal order: Should the partner cells be added before neuronal maturation, after a stable neural network forms, or only during a defined injury or treatment window?
• Attribution: How will a change be assigned to one cell type rather than to altered cell number, media incompatibility, general cytotoxicity, or a shift in the partner population?
• Scale and reproducibility: Does the project require mechanistic depth in a small cohort, medium-throughput imaging, multiwell MEA, or a screening-ready format with predefined acceptance criteria?

Select Neuronal and Partner Cell Sources

Cell source determines biological relevance, experimental control, supply, and throughput. Primary cells may provide rapid access to mature phenotypes but can vary by donor, isolation, age, species, and passage. iPSC-derived cells enable disease/control and isogenic comparisons, yet each lineage must be qualified for maturity and baseline state. Immortalized or engineered lines can support optimization and screening when the hypothesis does not require a primary-cell phenotype.

Primary and iPSC-Derived Neural Cells

Projects may use primary cortical, hippocampal, dopaminergic, motor, sensory, or project-specific neurons together with primary glia or other partner cells. Related cell sourcing can be supported through primary neuron culture and isolation, primary astrocyte culture and isolation, and primary microglia culture and isolation.

For human genetic or donor-specific questions, iPSC-derived neurons can be combined with matched or independently sourced astrocytes, microglia, or oligodendroglial cells. Available upstream support includes iPSC-derived neuron and neural progenitor cell generation, iPSC-derived astrocyte generation, iPSC-derived microglia generation, and iPSC-derived oligodendrocyte generation.

Disease, Control, and Isogenic Pairing

A disease phenotype can originate in neurons, partner cells, or both. A factorial design may therefore compare control neurons with control partner cells, disease neurons with control partner cells, control neurons with disease partner cells, and fully disease-matched co-culture. Isogenic correction or knock-in can strengthen attribution, while independent donors test generalizability. Donor, differentiation, plate, and well are retained as separate experimental levels rather than treated as interchangeable replicates.

Choose Direct, Compartmentalized, or Paracrine Interaction

The culture architecture should preserve the interaction needed for the hypothesis while keeping the readout interpretable. Direct contact is not automatically more physiological, and physical separation is not automatically less relevant. Geometry, sequence of assembly, coating, matrix, fluid volume, oxygenation, media composition, and sampling access can each change neuronal and glial state.

• Direct mixed co-culture. Cells share the same surface and medium, enabling contact-dependent and paracrine interactions. This format is suitable for synaptic support, phagocytosis, myelination, neurotoxicity, and high-content imaging when cell-specific markers or segmentation can distinguish populations.
• Sequential or staged assembly. One population is matured before the partner is introduced. Staging can prevent an immature or activated partner cell from distorting neuronal differentiation and can model an acquired inflammatory, degenerative, or repair phase.
• Transwell or insert-based co-culture. A permeable membrane supports soluble-factor exchange while preserving separate cell harvests. It is useful for cytokine, chemotaxis, barrier, secretome, and cell-specific omics questions, but pore size, diffusion, media depth, and membrane adsorption must be controlled.
• Conditioned-medium or extracellular-vesicle transfer. Defined transfer experiments isolate a paracrine mechanism and enable dose or neutralization studies. Donor-cell density, conditioning duration, medium depletion, normalization, carryover, freeze-thaw history, and recipient-cell exposure are documented.
• Compartmentalized or microfluidic co-culture. Separated soma, axon, or partner-cell chambers can distinguish local from distal effects, directional migration, axonal transport, and synaptic or neuromuscular interactions. Flow, hydrostatic pressure, channel geometry, and cross-compartment leakage are qualified.
• Two-dimensional versus 3D extension. A 2D co-culture is often preferable for controlled imaging, electrophysiology, perturbation, and cell recovery. When tissue architecture or multicellular diffusion is central, the program can transition to a neural spheroid, organoid, assembloid, or microglia-containing organoid after the 2D interaction has been qualified.

Link Cell-Specific Mechanism to Network Function

Readouts are selected so that a functional change can be traced to the relevant cellular mechanism. A decrease in firing, for example, may reflect synaptic inhibition, neuronal loss, altered astrocyte support, microglial activation, media stress, or reduced viable cell density. The assay package therefore combines a decision-driving endpoint with cell-specific identity, health, and mechanism controls.

• Neuronal structure and survival. Neuron number, subtype markers, MAP2 or beta-III-tubulin, neurite and axon length, branching, growth cones, synapse density, mitochondrial state, apoptosis, membrane integrity, and longitudinal live-cell measures can distinguish degeneration from reversible functional suppression. Focused studies may include the neuronal death assay.
• Astrocyte state and support. GFAP, S100B, ALDH1L1, EAAT1/2 or project-specific markers can be paired with morphology, glutamate uptake, metabolic support, cytokines, calcium signaling, and effects on neuronal maturation or survival. Reactive-state interpretation uses multiple markers rather than GFAP alone.
• Microglial response. IBA1, TMEM119, P2RY12 or project-specific markers can be combined with morphology, motility, clustering, phagocytosis, cytokines, complement, inflammasome signaling, pathological-protein uptake, synapse interaction, and neuronal consequences. Expanded work can use the microglia activation assay or microglia phagocytosis assay.
• Oligodendroglial and axon-glia endpoints. OPC proliferation and differentiation, OLIG2, PDGFR-alpha, O4, MBP, PLP1, myelin segment number and length, axon integrity, conduction-related measures, and response to demyelinating or remyelinating conditions can be integrated.
• Neural activity and network formation. Calcium dynamics, spontaneous and evoked firing, patch-clamp properties, multielectrode-array activity, mean firing rate, bursts, network bursts, synchrony, and pharmacological response can reveal maturation and rescue before overt cell loss. Related functional support includes neuronal MEA assays and calcium imaging assays.
• Soluble, molecular, and cell-resolved analysis. Cytokines, chemokines, neurotransmitters, neurotrophic factors, extracellular vesicles, secreted biomarkers, targeted transcripts or proteins, bulk and single-cell profiling, and sorted-cell analysis can connect the direction of signaling to the observed phenotype.
• Treatment response and safety. Small molecules, antibodies, proteins, peptides, oligonucleotides, viral vectors, nanoparticles, gene-modifying approaches, and project-specific modalities can be assessed for target engagement, cell-type selectivity, efficacy, exposure, washout, and cytotoxicity.

Related Research

The following studies illustrate two reasons to qualify a co-culture rather than treating it as a fixed mixture: the neuronal environment can reshape microglial identity and inflammatory behavior, and astrocyte-supported neural networks can acquire time-dependent electrical properties that require longitudinal functional measurement.

Neuronal Co-Culture Shapes iPSC-Derived Microglial State and LPS Response

Haenseler and colleagues developed human pluripotent stem cell-derived microglia in neuronal co-culture and reported a neuronal-environment-specific microglial expression profile. Under LPS challenge, live imaging showed changes in microglial morphology and clustering over time. The work supports a design in which microglial identity, baseline activation, cell density, motility, spatial organization, cytokines, and neuronal consequences are qualified together. It also demonstrates why a microglial monoculture control and an unstimulated co-culture control are both needed to interpret inflammatory phenotypes.

Fig. 1 LPS induces time-dependent morphological change and clustering in iPSC-derived microglia maintained with neurons.^1,3

Human Neuron-Astrocyte Co-Culture Develops Quantifiable Network Maturation

Lemieux and colleagues co-cultured NGN2-induced human iPSC-derived neurons with primary human astrocytes and followed network development on multielectrode arrays. Across days in vitro, the cultures showed increases in active electrodes, firing, network bursting, burst duration, and synchrony, together with more regular interburst timing. For service design, the study shows that cell ratio, plating density, differentiation batch, astrocyte passage, feeding schedule, recording time, and maturation window must be controlled before a treatment effect is interpreted.

Fig. 2 Human neuron-astrocyte co-cultures develop progressive and quantifiable network activity across days in vitro.^2,3

Frequently Asked Questions

1. Which neural cell combinations can Creative Biolabs develop?

   Creative Biolabs can develop neuron-astrocyte, neuron-microglia, neuron-OPC or oligodendrocyte, motor neuron-Schwann cell, neural-endothelial, neuron-muscle, and project-specific multicellular systems. Tri-cultures such as neuron-astrocyte-microglia can also be configured when the research question requires feedback among multiple populations.

2. Can primary cells and iPSC-derived cells be combined in one co-culture?

   Yes. A model can combine primary and iPSC-derived cells when species, donor background, maturity, medium compatibility, and the intended interpretation are addressed. Fully human, matched-donor, disease-control, and isogenic configurations may be recommended when translation or genetic attribution is important.

3. How do you choose between direct co-culture and a Transwell system?

   Direct co-culture is appropriate when physical contact, phagocytosis, myelination, synapse interaction, or shared imaging is required. A Transwell or insert-based system is useful when soluble signaling must be studied while the cell populations remain separately accessible. The choice depends on the causal interaction and the readout, not simply on model complexity.

4. How are cell ratio and co-culture timing optimized?

   A feasibility matrix can compare total density, partner-cell ratio, addition sequence, medium, coating or matrix, and culture duration. Conditions are evaluated against identity, viability, maturity, baseline activation, functional activity, batch variability, and the magnitude and reproducibility of the disease or treatment phenotype.

5. What quality controls are included for neural co-culture models?

   Quality control can include cell identity and purity, viable cell number, neuronal subtype and maturity, neurite or axon structure, astrocyte and microglial baseline state, OPC or oligodendrocyte stage, cytokine background, morphology, batch consistency, spontaneous neural activity, and response to positive and negative controls.

6. Which readouts are available for neural co-culture studies?

   Studies can combine high-content imaging, cell survival, neurite and synapse analysis, phagocytosis, cytokines, complement, glutamate handling, myelination, target engagement, calcium imaging, patch clamp, multielectrode-array activity, neurotransmitters, extracellular vesicles, biomarkers, and cell-resolved molecular or omics analysis.

7. Can neural co-cultures be used for efficacy and neurotoxicity testing?

   Yes. Small molecules, antibodies, proteins, peptides, oligonucleotides, viral vectors, nanoparticles, gene-modifying approaches, and other modalities can be evaluated. The study can distinguish cell-type-selective efficacy, reversible functional suppression, general cytotoxicity, target engagement, exposure, and rescue across cellular and network endpoints.

8. What information is needed to start a custom neural co-culture project?

   Helpful inputs include the initiating and responding cell types, species and donor requirements, disease or injury hypothesis, preferred interaction format, test article, treatment schedule, primary endpoint, required cell-specific readouts, comparator conditions, throughput, timeline, sample needs, and the decision the data must support.

References

1. Haenseler, Walther, et al. "A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response." Stem Cell Reports, vol. 8, no. 6, 2017, pp. 1727-1742. https://doi.org/10.1016/j.stemcr.2017.05.017
2. Lemieux, Maddie R., et al. "Multielectrode Array Characterization of Human Induced Pluripotent Stem Cell Derived Neurons in Co-Culture with Primary Human Astrocytes." PLOS ONE, vol. 19, no. 6, 2024, e0303901. https://doi.org/10.1371/journal.pone.0303901
3. Distributed under Open Access license CC BY 4.0, without modification.